DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Jacobson IM, Dore GJ, Foster GR. et al.
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet 2014;
384 (9941): 403-413
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.